//www sec.gov/Archives/edgar/data/1141982/000095012905001490/h22660el0vk htm 2/6/2006 elOvk Page 6 of 84 Table of Contents Segment Electrical Products Tools & Hardware Other Total Number of Employees 21,119 _________ Number and Nature of Facilities_________ Manufacturing Warehouse Sales Other 72 47 105 16 5,477 23 11 20 2 267 0 0 0 1 Square Footage of Plants and Facilities Owned Leased 9,868,895 3,625,779 3,788,060 453,919 0 137,853 26,863 95 58 125 19 13,656,955 4,217,551 Multi-purpose facilities at a single location are listed in each applicable column Segment Electrical Products Tools & Hardware Manufacturing Plant Locations United States Europe (Other Than UK) United Kingdom Mexico South America Australia Canada China Republic of China India Malaysia 35 11 99 2 1 11 11 1 11 7 02 2 1 00 00 0 Total 46 18 9 11 4 2 11 11 1 Does not include joint venture operations 3 http //www sec gov/Archives/edgar/data/1141982/000095012905001490/h22660el0vk.htm 2/6/2006 elOvk Page 7 of 84 Table of Contents Operations in the United States are conducted by wholly-owned subsidiaries of Cooper, organized by the two business segments Activities outside the United States contribute significantly to the revenues and operating earnings of both segments of Cooper These activities are conducted in major commercial countries by wholly-owned subsidiaries and jointlyowned companies, the management of which is structured through Cooper's two business segments As a result of these international operations, sales and distribution networks are maintained throughout most of the industrialized world Cooper generally believes that there are no substantial differences in the business risks associated with these international operations compared with domestic activities, although Cooper is subject to certain political and economic uncertainties encountered in activities outside the United States, including trade barriers, restrictions on foreign exchange and currency fluctuations The five countries in which Cooper generates the most international revenues are Canada, Germany, France, Mexico and the United Kingdom Cooper has operations in India, Malaysia and China and has several joint ventures with operations in China Investments in India, Malaysia and China are subject to greater risks related to economic and political uncertainties as compared to most countries where Cooper has operations Exhibit 21 0 contains a list of Cooper's subsidiaries Financial information with respect to Cooper's industry segments and geographic areas is contained in Note 15 of the Notes to the Consolidated Financial Statements A discussion of acquisitions and divestitures is included in Notes 3, 7 and 16 of the Notes to the Consolidated Financial Statements With its two business segments, Cooper serves three major markets industrial, construction and electrical power distribution Cooper also serves the electronics and telecommunications markets Markets for Cooper's products and services are worldwide, though the United States is the largest market Within the United States, there is no material geographic concentration by state or region Cooper experiences substantial competition in both of its business segments The number and size of competitors vary considerably depending on the product line Cooper cannot specify with exactitude the number of competitors in each product category or their relative market position However, most operating units experience significant competition from both larger and smaller companies with the key competitive factors being price, quality, brand name and availability Cooper considers its reputation as a manufacturer of a broad line of quality products and premier brands to be an important factor in its businesses Cooper believes that it is among the leading manufacturers in the world of electrical distribution equipment, wiring devices, support systems, hazardous duty electrical equipment, emergency lighting, lighting fixtures, fuses, nonpower hand tools and industrial power tools .

Page 1 1 CAUSE NO.

(See Exhibit B) Some of these other PFCs, including PFBS (C-4), already have been detected in the blood of area residents, leading to very high cumulative PFC levels in their blood.

The following personnel from Exygen Research were associated with various phases of this interim portion o f the study: Name John Flaherty Karen Risha Paul Connolly Amy Sheehan Christine Edwards Brittany Kravets Mindy Cressley Krista Gallant Scott Crain Eric Hoover Carlyle Horrell Shawn Robb Mark Ammerman Eric Edwards Edward Cams Title Vice President Laboratory Supervisor Technical Lead-LC/MS Associate Scientist Technician Technician Technician Technician Technician Technician Intern Technician Technical Lead Facilities Sample Custodian Sample Custodian Sample Custodian Exygen Research Page 6 of 132 p.7 Interim Report #10-Analysis of Fish and Clam Samples - - Exygen Study No.: P0001131 TABLE OF CONTENTS Page TITLE PAGE......................................................................................................................... 1 GOOD LABORATORY PRACTICE COMPLIANCE STATEMENT..............................2 QUALITY ASSURANCE STATEMENT........................................................................... 3 CERTIFICATION OF AUTHENTICITY............................................................................4 STUDY IDENTIFICATION................................................................................................. 5 PROJECT PERSONNEL...................................................................................................... 6 TABLE OF CONTENTS...................................................................................................... 7 LIST OF TABLES.................................................................................................................8 LIST OF FIGURES................................................................................................................9 LIST OF APPENDICES......................................................................................................10 1.0 SUMMARY..................................................................................................................11 2.0 OBJECTIVE................................................................................................................. 12 3.0 INTRODUCTION............................................. 13 4.0 ANALYTICAL TEST SAMPLES............................................................................ 13 5.0 REFERENCE MATERIAL..........................................................................................13 6.0 DESCRIPTION OF ANALYTICAL METHOD......................................................... 15 6.1 Extraction Procedure..................................................................................................15 6.1.1 Sample Preparation..................................................................................... 15 6.1.2 Glassware Preparation................................................................................. 15 6.1.3 Column Preparation.................................................................................... 15 6.1.4 Sample Extraction....................................................................................... 15 6.2 Preparation o f Standards and Fortification Solutions................................................16 6.3 Chromatography.........................................................................................................17 6.4 Instrument Sensitivity................................................................................................ 17 6.5 Description o f LC/MS/MS Instrument and Operating Conditions........................... 17 6.6 Quantitation and Example Calculation...................................................................... 18 7.0 EXPERIMENTAL DESIGN....................................................................................... 20 8.0 RESULTS.................................................................................................................... 20 9.0 CONCLUSIONS.......................................................................................................... 21 10.0 RETENTION OF DATA AND SAMPLES..............................................................21 Exygen Research Page 7 of 132 p.8 Interim Report #10-Analysis of Fish and Clam Samples Exygen Study No.: P0001131 LIST OF TABLES Eag Tabic I.

file:///C|/Users/MadeK42/Desktop/Reese%20Depo%2010-10-06.txt 0001 1 IN THE COURT OF COMMON PLEAS 2 CUYAHOGA COUNTY, OHIO 3 JUDGE HANNA 4 CV-588713 5 6 LOWELL WAYNE REESE; et al., 7 Plaintiffs, 8 9 V. 10 11 A.

BACK TO MAIN Biodegradation study Report The Aerobic Biodegradation of W-EtFOSE Alcohol by the Microbial Activity Present in Municipal Wastewater Treatment Sludge Thursday, November 02, 2000 Project Number 3M Project ID: LIMS E00-2252 Pace Contract Analytical Project ID: CA058 Pace Proposal ID: 000511.1 Principal Analytical Investigator Cleston C.

The following personnel from Exygen Research were associated with various phases of this interim portion of the study: Name Title John Flaherty Vice President Karen Risha Scientist Paul Connolly Technical Lead-I,CJMS Christine Edwards Technician Mark Ammerman Sample Custodia n Amy Sheehan Associate Scientist Brittany Kravets Technician Scott Crain Technicia n Frances Crespi Technician Devon Ingrain Technician Christa Gallant Technician Exygen Research Page 6 of 110 p. 7 Interim Repo rt #23 - Analysis of Sediment Samples Exygen Study No . : P0000760 TABLE OF CONTENTS Page TITLE PAGE .. . . . . .. . . . . . . . . . . . .. . . .. .. . ... . . . . . . . .. . . . . .. . . .. . . . . . . . . .. .. . . . . . . . .. . . . . . . .. . . . . . .. . . ... . . . . . . . . . . . . .. . . . . .. . . . . . . .I GOOD LABORATORY PRACTICE COMPLIANCE STATEMENT . . . . . . . . . . . . . . . . . . . . . .. . . . . . . .2 QUALITY ASSURANCE STATEMENT . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..3 CERTIFICATION OF AUTHENTICITY . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..4 STUDY IDENTIFICATION . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . .5 PROJECT PERSONNEL. . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . .. . . . . . . . .. . . . . . . . . . .. . . .. . .. . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6 TABLE OF CONTENTS . . . . . . .. . .. . . . . . .. . . . . . . . . . . . . .. . .. . . . . . . . . . . . .. . . . . . . .. . .. . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..7 LIST OF TABLES . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..8 LIST OF FIGURES . . . . . . . . .. . .. . .. . . . . . . . . . . . . . . . . . . . . . .. .. . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . .. . . . . . . . . .. . . . . . . .9 LIST OF APPENDICES . . . .. . . . . . . . . . . . . . . . .. . . . . . .. . . . . . .. . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . .. . . . . . . . . .10 1 .0 SUMMARY . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . .. . . . . . . . . .11 2 .0 OBJECTIVE . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . .11 3 .0 INTRODUCTION . . . .. . .. . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . .. . . . . . . . . . .. . .. . .12 4 .0 ANALYTICAL TEST SAMPLES . . .. . .. . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .12 5 .0 REFERENCE MATERIAL . . . . . . .. . . . . .. . . . . . . . . . . .. . . . . .. . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . .. . . . . . . . . .12 6 .0 DESCRIPTION OF ANALYTICAL METHOD . . . . . . . . . . .. . . . . . .. . . .. . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . ., .1 3 6 .1 Extraction Procedure For Sediment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .. . . .. . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . .13 6 .2 Direct Inject Extraction Procedure For Sediment . . . . . . . . . . .. . . .. . . . . . . . . . . . . . . . . .. . . . . . . .. . . . . . . . . . . .14 6 .3 Additional SPE Extraction Procedure For Sediment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14 6 .4 Percent Solids Procedure For Sediment . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . .. . .14 6 .5 Preparation of Standards and Fo rtification Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14 6 .6 Chromatography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .16 6 .7 Instrument Sensitivi ty . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . .16 6

3M Medical Department Study: T-6295.22 Analytical Report: FACT-TOX- 160 LIMS E00-1668 3M Medical Department Study: T-6295.22 Analytical Report: FACTTOX-160 LIMS E00-1668 Study Title Extended Recovery Study Followinga 26-Week Capsule Toxicity Study (FACT-TOX-030) with Perfluorooctane SulfonateAcid Potassium Salt (PFOS; T-6295.22) in Cynomolgus Monkeys Analytical Laboratory Report Title Determination of the Presence and Concentration of PFOS in Serum and Liver Samples of Cynomolgus Monkeys Data Requirement Not Applicable Author 3M Environmental Laboratory Study Completion Date May 3, 2002 Performing Sera and Liver Analyses 3M EnvironmentaLlaboratory Building2-3E-09,935 BushAvenue St.

ANTONIA TOLBERT, et al. v.

Taft/ Taft Stettinius & Hollister LLP 425 Walnut Street, Suite 1 8 0 0 /Cincinnati, OH 45202-3957/Tel: 513.381.2838/Fax: 513.381.0205/ www.taftlaw.com Cincinnati / Cleveland / Columbus / Dayton / Indianapolis / Northern Kentucky / Phoenix / Beijing Robert a .

1 CAUSE NO.

(See Exhibit B) Some of these other PFCs, including PFBS (C-4), already have been detected in the blood of area residents, leading to very high cumulative PFC levels in their blood .

Final Interim Analytical Report Review 01/05/07 01/09/07 01/09/07 01/09/07 Lydia Shaffer Technical Lead, Quality Assurance Unit Date 'Note: All in-lab inspections will be documented in the QA statement for the final analytical report at the conclusion of the study.

Chest Xrays were not, in general, recommended for mass screening purposes, although the possibility that an increased frequency of chest X-ray screening might lead to a reduced case fatality rate was believed to be worth further investigation.

IM Genera Offices SMt PCaeln,teMrN S5144-1000 $173 1010 October 31,2009 Submitted Via E-Mail Agency for Toxic Substancaends Disease Registry DivisionofToxicology and Environmental Medicine 1600 Clifton Road NE Mail Stop F-62 Atlanta, GA 30333 Re: Draft Toxicological Profile for Perfluoroalkyls Dear Sir/Madam: 3M is responditnog the Agency for Toxic Substances and Disease Registry'sdraft Toxicological Profile for perfluoroalkyls.